IN2013MU01510A - - Google Patents
Info
- Publication number
- IN2013MU01510A IN2013MU01510A IN1510MU2013A IN2013MU01510A IN 2013MU01510 A IN2013MU01510 A IN 2013MU01510A IN 1510MU2013 A IN1510MU2013 A IN 1510MU2013A IN 2013MU01510 A IN2013MU01510 A IN 2013MU01510A
- Authority
- IN
- India
- Prior art keywords
- relates
- bendamustine
- treatment
- nitrogen
- disease states
- Prior art date
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- ZHSKUOZOLHMKEA-UHFFFAOYSA-N 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydron;chloride Chemical compound Cl.ClCCN(CCCl)C1=CC=C2N(C)C(CCCC(O)=O)=NC2=C1 ZHSKUOZOLHMKEA-UHFFFAOYSA-N 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 229960002707 bendamustine Drugs 0.000 abstract 1
- YTKUWDBFDASYHO-UHFFFAOYSA-N bendamustine Chemical compound ClCCN(CCCl)C1=CC=C2N(C)C(CCCC(O)=O)=NC2=C1 YTKUWDBFDASYHO-UHFFFAOYSA-N 0.000 abstract 1
- 229960001215 bendamustine hydrochloride Drugs 0.000 abstract 1
- -1 e.g. Chemical compound 0.000 abstract 1
- 229960004961 mechlorethamine Drugs 0.000 abstract 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1510MU2013 IN2013MU01510A (enrdf_load_stackoverflow) | 2013-04-25 | 2013-04-25 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1510MU2013 IN2013MU01510A (enrdf_load_stackoverflow) | 2013-04-25 | 2013-04-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU01510A true IN2013MU01510A (enrdf_load_stackoverflow) | 2015-04-17 |
Family
ID=54394694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1510MU2013 IN2013MU01510A (enrdf_load_stackoverflow) | 2013-04-25 | 2013-04-25 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU01510A (enrdf_load_stackoverflow) |
-
2013
- 2013-04-25 IN IN1510MU2013 patent/IN2013MU01510A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022001105A (es) | Anticuerpos anti tigit. | |
| TW201613901A (en) | New compounds | |
| MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
| MY186047A (en) | Eutectic formulations of cyclobenzaprine hydrochloride | |
| MX2021011906A (es) | Composiciones de liberacion retardada de linaclotida. | |
| NZ708727A (en) | Conjugate compounds | |
| HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| MX2017004473A (es) | Formulaciones de betalactamasa y usos de las mismas. | |
| EA201690513A1 (ru) | Комбинация ингибитора mek и ингибитора erk для применения в лечении гиперпролиферативных заболеваний | |
| IN2014MN02236A (enrdf_load_stackoverflow) | ||
| IN2013MU03583A (enrdf_load_stackoverflow) | ||
| CL2018000565A1 (es) | Compuestos derivados de piridinona dicarboxamida, inhibidores de bromodominio; composicion farmaceutica; combinacion farmaceutica; utiles en el tratamiento de enfermedades autoinmunitarias, inflamatorias, virales y cancer, entre otras. | |
| EA201591758A1 (ru) | Подкожное введение adamts13 | |
| MX2022006770A (es) | Dispersiones solidas de bendamustina e infusion continua. | |
| EP4331622A3 (en) | Integrin binding peptides and uses thereof | |
| TR201905218T4 (tr) | Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler. | |
| EA201591717A1 (ru) | Твердые формы гидрохлорида вемурафениба | |
| PH12017501979A1 (en) | Pharmaceutical compound | |
| IN2013MU01510A (enrdf_load_stackoverflow) | ||
| WO2014170769A3 (en) | Bendamustine lyophilized pharmaceutical compositions | |
| WO2015003049A3 (en) | Compositions and methods to treat inflammatory joint disease | |
| MX2018000418A (es) | Derivados de amida que tienen actividad multimodal contra el dolor. | |
| EA201791648A1 (ru) | Комбинация гиалуроновой кислоты и макроголя и фармацевтические композиции, содержащие ее | |
| IN2014KN02584A (enrdf_load_stackoverflow) |